(Q37906758)

25 August 2017

1 reference

title

Antifungal susceptibility of Candida albicans in biofilms (English)

1 reference

25 August 2017

0 references

1 reference

Selma Tobudic

1

1 reference

25 August 2017

Christina Kratzer

series ordinal

2

1 reference

25 August 2017

Andrea Lassnigg

series ordinal

3

1 reference

25 August 2017

Elisabeth Presterl

series ordinal

4

1 reference

25 August 2017

publication date

28 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

55

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

199-204

1 reference

Pathogenesis of invasive candidiasis

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Overview of microbial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biofilms as complex differentiated communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Mechanisms of biofilm resistance to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Candida biofilms and their susceptibility to antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Persister cells and tolerance to antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Candida albicans biofilms produce antifungal-tolerant persister cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Uses and limitations of the XTT assay in studies of Candida growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Current and future antifungal therapy: new targets for antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Resistance of Candida albicans biofilms to antifungal agents in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated Candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Antifungal combinations against Candida albicans biofilms in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

In vitro activity of antifungal combinations against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2011.02076.X

10.1111/J.1439-0507.2011.02076.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference